Rheumatology
Behçet's Disease
Recurrent oral + genital ulcers + uveitis + skin lesions — variable systemic involvement (vascular, neuro, GI), corticosteroid + steroid-sparing.
Source: EULAR 2018; ISG 1990 criteria
Step 1 of ~3
info
ISG Criteria
Recurrent oral ulceration (≥3/year) + 2 of:
• Recurrent genital ulceration.
• Eye disease (anterior / posterior uveitis, retinal vasculitis).
• Skin lesions (erythema nodosum, pseudofolliculitis, papulopustular).
• Positive pathergy test (sterile pustule at site of needle prick within 24–48h).
Common along Silk Road (Turkey, Mediterranean, Middle East, Far East). HLA-B51 association.
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
- Methylprednisolone · Systemic Corticosteroid (IV Pulse / Depot)
- Prednisolone (Oral — Nasal Polyp Reduction) · Systemic Corticosteroid
- Dexamethasone (ICU / ARDS) · Systemic Corticosteroid
- Dapsone · Anti-inflammatory / Antimicrobial
- Terbinafine (Oral) · Systemic Antifungal — Onychomycosis / Tinea
- Prednisolone (Systemic) · Systemic Corticosteroid — Acute Dermatoses
Pathways
- Cutaneous Lupus Erythematosus · BAD; EULAR
- Osteoporosis / Fragility Fracture · NOGG 2021; NICE NG147; NG224
- Arteritic AION (Giant Cell Arteritis) · RCOphth; BSR
- Osteoarthritis Hip / Knee Management · NICE NG226 (2022)
- Lupus Nephritis · EULAR/ERA-EDTA 2019; KDIGO 2024
- Rheumatoid Arthritis Management · NICE CG79 2018 / EULAR 2022
Decision support only. Always apply local guidelines and clinical judgement.